Consistent with prior research, AFP was significantly elevated in HCC patients, whereas CA19-9 levels were higher in ICC patients.[21] However, relying solely on tumor markers offers limited sensitivity and specificity. This evidence concerns the gene AFP and hepatocellular carcinoma.